Market-wide·August 20, 2026·AM edition

Market Pulse, 2026-08-19 AM

What moved, what the tape is saying, and what the day's coverage was actually about.

The tape

The broad market reads risk-on, cyclicals leading defensives with the index above its 200-day average. The S&P proxy sits 9.2% above its 200-day average, +2.8% over the past month.

Under the surface: XLK +1.6%, XLV +9.6%, XLE +8.7%, XLF +2.4%, XLU -2.0% on a one-month basis.

What moved

Up: MRNA +177.0%, EL +16.3%, MRK +12.6%, ARE +10.3%, MRVL +9.8%.

Down: STX -7.9%, STLD -7.5%, WDC -6.9%, DELL -6.6%, LRCX -6.3%.

Moderna led the upside at +177.0%, which against its 189.6% annualized volatility is an outsized session, not ordinary noise.

Rates and the long end

Long rates were broadly flat over the past month: TLT, the 20-year Treasury proxy, is -0.4% on the month and +0.9% on the year, with the 7-10 year at +0.4% and the front end at +0.5%. Because bond prices move opposite to yields, a falling proxy means a rising yield.

Gold is +10.4% on the month and +34.8% on the year, worth watching alongside real rates, since the two usually pull in opposite directions.

What the coverage was about

Dominating the day: AI & Semiconductors (72 weighted mentions across business coverage, 53 across retail forums). Second: Rates & Bonds (35 weighted mentions across business coverage, 59 across retail forums). Third: Earnings Season (39 weighted mentions across business coverage, 51 across retail forums).

The names drawing the most attention across both channels: MRNA, TTD, NVDA, MU, HOOD, SNDK, AMD, RDDT. Attention is not a signal on its own, it is a measure of where crowding is building, which is useful mostly as a caution.

How this was built

Theme rankings come from counting keyword matches across publisher syndication feeds and public forum listings, weighted by source. Price figures come from daily adjusted closes. No article text is reproduced and no source is quoted; the coverage is an input to what we chose to write about, not to the analysis itself.

Nothing here is tailored to your situation, and nothing here is a recommendation to buy or sell.

Free newsletter

Get the next edition before anyone asks you to pay

Two editions a weekday, free, the same rankings, the same published method. Unsubscribe in one click.

Screenline publishes impersonal, rules-based rankings on a fixed schedule. The same content goes to every reader. Nothing here is tailored to your circumstances and nothing here is a recommendation to buy or sell any security. We are not a registered investment adviser. Rankings are computed from historical price data, which may contain errors. Past performance does not predict future results.